Immunomics technologies using protein microarrays for biomarker research

Join Andreas Weinhausel from the Austrian Institute of Technology (AIT) and learn about the role of biomarkers in the clinical diagnosis and therapeutic treatment of rheumatoid arthritis.

Antibodies and autoantibodies make suitable biomarkers for the prediction and monitoring of disease. Sero-testing of plasma or serum is minimally invasive, and immunomics analysis has great potential for the diagnostics of autoimmune, cancerous, cardiologic, neurodegenerative, and systemic conditions.

Speaker Bio

Andreas is a biotechnologist and associate professor for molecular biology at the University of Natural Resources and Applied Life Sciences, Vienna. He has been at the Molecular Diagnostics business unit at AIT since 2004, specialising in DNA-methylation and autoantibody biomarker development high throughput technologies. This new workflow combines microarray and bead array technologies for biomarker development. Probing antigenic proteins and peptides, the platform offers a powerful solution for diagnosing cancer and autoimmune disease.

This webinar is available on Zoom.

Click here to watch a recording of this event online. The link will redirect you to

In partnership with...

Speak to an expert

Get advice on the best solution for your application

Arrange a consultation with one of our team to find out more about Arrayjet, our ground-breaking tech and World-class services.  You can also arrange to see our instruments for yourselves at our headquarters in Edinburgh, or visit one of our global reference sites.